Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model.

Mar Drugs · 2021 · PMC8306302 · PMID 34201848

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Supplementation of COS (0.5–5%) to the DF diabetic rats showed an increasing trend in plasma insulin level, but there was no significant difference ( p > 0.05 vs.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.